Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B

FEMS Immunology and Medical Microbiology

Volumn 56, Issue 3, 2009, Pages 197-203

  Gu, Qing ^a   Song, Dafeng ^a   Zhu, Muyuan ^b  

^a ZHEJIANG GONGSHANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Helicobacter pylori; Lactococcus lactis; UreB; Vaccine

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; UREASE; UREASE SUBUNIT B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FECES; FEMALE; GASTROINTESTINAL INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; LACTOCOCCUS LACTIS; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; COLONY COUNT, MICROBIAL; FECES; GENE EXPRESSION; GENETIC VECTORS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOCOCCUS LACTIS; MICE; MICE, INBRED BALB C; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; STOMACH; UREASE;

EID: 67650757275     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2009.00566.x     Document Type: Article

References (38)

1. Adams MR Marteau P (1995) On the safety of lactic acid bacteria from food. Int J Food Microbiol 27 : 263 264.
2. Bahey-El-Din M, Casey PG, Griffin BT Gahan CG (2008) Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model. Vaccine 26 : 5311 5321.
3. Bazzoli F, Pozzato P Rokkas T (2002) Helicobacter pylori: the challenge in therapy. Helicobacter 7 : 43 49. (Pubitemid 35230814)
4. Del Giudice G, Covacci A, Telford JL, Montecucco C Rappuoli R (2001) The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 19 : 523 563. (Pubitemid 32368045)
5. Dieye Y, Hoekman AJ, Clier F, Juillard V, Boot HJ Piard JC (2003) Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines. Appl Environ Microb 69 : 7281 7288. (Pubitemid 38585380)
6. Enouf V, Langella P, Commissaire J, Cohen J Corthier G (2001) Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic. Appl Environ Microb 67 : 1423 1428. (Pubitemid 33644904)
7. Ferrero RL, Thiberge JM, Huerre M Labigne A (1994) Recombinant antigens prepared from the urease subunits of Helicobacter pylori spp.: evidence of protection in a mouse model of gastric infection. Infect Immun 62 : 4981 4989. (Pubitemid 24332805)
8. Genta RM, Robason GO Graham DY (1994) Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol 25 : 221 226. (Pubitemid 24116235)
9. Harris PR, Mobley HL, Perez-Perez GI, Blaser MJ Smith PD (1996) Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 111 : 419 425. (Pubitemid 26256730)
10. Holo H Nes IF (1989) High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl Environ Microb 55 : 3119 3123. (Pubitemid 20002122)
11. Kotloff KL, Sztein MB, Wasserman SS, Losonsky GA, DiLorenzo SC Walker RI (2001) Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 69 : 3581 3590. (Pubitemid 32493271)
12. Lamm ME (1997) Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 51 : 311 340. (Pubitemid 27433052)
13. Lee MH, Roussel Y, Wilks M Tabaqchali S (2001) Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 19 : 3927 3935. (Pubitemid 32566316)
14. Mannam P, Jones KF Geller BL (2004) Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun 72 : 3444 3450. (Pubitemid 38697770)
15. Marchetti M, Rossi M, Giannelli V et al 1998) Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 16 : 33 37. (Pubitemid 27504801)
16. Mercenier A, Muller-Alouf H Grangette C (2000) Lactic acid bacteria as live vaccines. Curr Issues Mol Biol 2 : 17 25.
17. Michetti P (1997) Vaccine against Helicobacter pylori: fact or fiction? Gut 41 : 728 730. (Pubitemid 28023171)
18. Norton PM, Brown HW, Wells JM, Macpherson AM, Wilson PW Le Page RW (1996) Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis. FEMS Immunol Med Mic 14 : 167 177. (Pubitemid 26186268)
19. Nouaille S, Ribeiro LA, Miyoshi A, Pontes D, Le Loir Y, Oliveira SC, Langella P Azevedo V (2003) Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res 2 : 102 111. (Pubitemid 38846553)
20. Nyström J Svennerholm AM (2007) Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses. Vaccine 25 : 2591 2598. (Pubitemid 46400933)
21. Pei H, Liu J, Cheng Y, Sun C, Wang C, Lu Y, Ding J, Zhou J Xiang H (2005) Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination. Appl Microbiol Biot 68 : 220 227. (Pubitemid 41110944)
22. Que YA, Haefliger JA, Francioli P Moreillon P (2000) Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infect Immun 68 : 3516 3522. (Pubitemid 30340452)
23. Ramasamy R, Yasawardena S, Zomer A, Venema G, Kok J Leenhouts K (2006) Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine 24 : 3900 3908.
24. Rappuoli R, Pizza M, Douce G Dougan G (1999) Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol Today 20 : 493 500. (Pubitemid 29507092)
25. Ribeiro LA, Azevedo V, Le Loir Y, Oliveira SC, Dieye Y, Piard JC, Gruss A Langella P (2002) Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl Environ Microb 68 : 910 916. (Pubitemid 34113084)
26. Robinson K, Chamberlain LM, Schofield KM, Wells JM Le Page RW (1997) Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 15 : 653 657. (Pubitemid 27291166)
27. Robinson K, Chamberlain LM, Lopez MC, Rush CM, Marcotte H, Le Page RW Wells JM (2004) Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect Immun 72 : 2753 2761. (Pubitemid 38542403)
28. Schägger H von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166 : 368 379. (Pubitemid 18004907)
29. Seegers JF (2002) Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol 20 : 508 515. (Pubitemid 35356405)
30. Sutton P, Wilson J Lee A (2000) Further development of the Helicobacter pylori mouse vaccination model. Vaccine 18 : 2677 2685. (Pubitemid 30211575)
31. Telford JL Ghiara P (1996) Prospect for the development of a vaccine against Helicobacter pylori. Drugs 52 : 799 804. (Pubitemid 26413291)
32. Thole JE, van Dalen PJ, Havenith CE, Pouwels PH, Seegers JF, Tielen FD, van der Zee MD, Zegers ND Shaw M (2000) Live bacterial delivery systems for development of mucosal vaccines. Curr Opin Mol Ther 2 : 94 99. (Pubitemid 30140209)
33. Warren JR Marshall BJ (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1 : 1273 1275.
34. Wells JM Mercenier A (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6 : 349 362. (Pubitemid 351552656)
35. Wells JM, Wilson PW, Norton PM, Gasson MJ Le Page RW (1993) Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol 8 : 1155 1162.
36. Wells JM, Robinson K, Chamberlain LM, Schofield KM Le Page RW (1996) Lactic acid bacteria as vaccine delivery vehicles. Antonie Van Leeuwenhoek 70 : 317 330. (Pubitemid 26355506)
37. Williams CL, Preston T, Hossack M, Slater C McColl KE (1996) Helicobacter pylori utilizes urea for amino acid synthesis. FEMS Immunol Med Mic 13 : 87 94. (Pubitemid 26036176)
38. Xin KQ, Hoshino Y, Toda Y et al 2003) Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 102 : 223 228. (Pubitemid 36759658)